Covalent Ventures

Covalent Ventures is a globally connected food and health impact investor founded in 2021 and headquartered in Auckland, New Zealand, with additional presence in Switzerland. The firm focuses on Series A health and wellness investments, actively working with portfolio companies to scale into major global markets across the Asia-Pacific region, Switzerland, and the United States. Partner Kelvin Keh brings more than 20 years of international healthcare experience spanning biotech and pharma, medical devices, digital health, nutrition, and consumer packaged goods. The combined investment team holds 50 or more years of sector experience and a track record of at least 17x growth. Covalent deploys checks of $500,000 to $4 million per company with a sweet spot of $2 million, investing across seed through Series B stages in 11 portfolio companies. Sector coverage spans food systems, nutrition science, biotech, pharmaceutical, medical devices, digital health, healthcare systems, novel ingredients, and cell and gene therapy — a deliberately broad mandate within the health and food impact thesis. The firm's investment philosophy holds that human health is inseparable from food systems, and that the most consequential companies in this space bridge both domains. Covalent works alongside founders to access green and brownfield markets — new categories as well as established markets ripe for disruption — bringing sector expertise and a global network to bear on the commercial challenges that health and food technology companies face as they scale from early traction to institutional scale.